NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer’s Disease.
Journal of Alzheimer’s Disease; doi: 10.3233/JAD-151203.
Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment
Biochim Biophys Acta Mol Basis Dis.; doi: 10.1016/j.bbadis.2016.11.020.
Multivalent foldamer-based affinity assay for selective recognition of Aβ oligomers.
Analytica Chimica Acta; https://doi.org/10.1016/j.aca.2017.01.013.
Amyloid-beta Peptide Decreases Expression and Function of Glutamate Transporters in Nervous System Cells.
The International Journal of Biochemistry & Cell Biology; http://dx.doi.org/10.1016/j.biocel.2017.01.017.
Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer’s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
CNS Drugs; 10.1007/s40263-017-0434-z.
Rattle-Structured Upconversion Nanoparticles for Near-IR-Induced Suppression of Alzheimer's β-Amyloid Aggregation
Small; DOI:10.1002/smll.201603139.
Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease.
PLOS One; doi: 10.1371/journal.pone.0182194.
Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42.
FEBS Letters; https://doi.org/10.1002/1873-3468.12590.
Covalent modifications of the amyloid beta peptide by hydroxynonenal: Effects on metal ion binding by monomers and insights into the fibril topology.
Journal of Inorganic Biochemistry; DOI: 10.1016/j.jinorgbio.2017.06.007.
Carbon Nanodot‐Sensitized Modulation of Alzheimer's β‐Amyloid Self‐Assembly, Disassembly, and Toxicity.
Small; doi: 10.1002/smll.201700983.